These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8697885)

  • 21. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC; Chen YH; Chen YC; Lu PL
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
    Abastabar M; Zaedi A; Shabanzadeh S; Nosratabadi M; Moazeni M; Aghili SR; Haghani I; Khojasteh S; Javidnia J; Nargesi S; Shokohi T; Hedayati MT; Meis JF; Badali H
    Mycoses; 2022 Nov; 65(11):981-988. PubMed ID: 35689417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.
    Kiraz N; Dag I; Oz Y; Yamac M; Kiremitci A; Kasifoglu N
    J Microbiol Methods; 2010 Aug; 82(2):136-40. PubMed ID: 20493911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M; Scaltrito MM; Morace G;
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
    Pakshir K; Ghasemi N; Zomorodian K; Jowkar F; Nouraei H; Dastgheib L
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):137-141. PubMed ID: 31542055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    BMC Infect Dis; 2005 Nov; 5():99. PubMed ID: 16266438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis.
    De-la-Torre J; Ortiz-Samperio ME; Marcos-Arias C; Marichalar-Mendia X; Eraso E; Echebarria-Goicouria MÁ; Aguirre-Urizar JM; Quindós G
    Mycopathologia; 2017 Jun; 182(5-6):471-485. PubMed ID: 28124220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro resistance to fluconazole and itraconazole in clinical isolates of Candida spp and Cryptococcus neoformans].
    Carrillo Muñoz AJ; Tur C; Estivill D; Montsant L; Carceller A; Hernández-Molina JM; Torres Rodríguez JM
    Rev Iberoam Micol; 1997 Jun; 14(2):50-4. PubMed ID: 16854170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G; Carrillo-Muñoz AJ; Arévalo MP; Salgado J; Alonso-Vargas R; Rodrigo JM; Ruesga MT; Valverde A; Pemán J; Cantón E; Martín-Mazuelos E; Pontón J
    Chemotherapy; 2000; 46(6):395-401. PubMed ID: 11053905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
    Ellabib MS; ElJariny IA
    Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H; Kerridge D
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
    Lu JJ; Lee SY; Chiueh TS
    J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
    Odds FC; Cheesman SL; Abbott AB
    Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
    Mallié M; Bastide JM
    Drugs Exp Clin Res; 1996; 22(6):301-7. PubMed ID: 9034756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.